all report title image

CELL THERAPY MANUFACTURING MARKET ANALYSIS

Cell Therapy Manufacturing Market, By Therapy Type (Allogeneic Cell Therapy and Autologous Cell Therapy), By Technology Type (Somatic Cell Technology, Cell Immortalization Technology, Viral Vector Technology, Genome Editing Technology, Cell Plasticity Technology, 3D Technology), By Manufacturing Purpose (Clinical, Commercial, Pre-clinical), By Application (Musculoskeletal, Cardiovascular, Gastrointestinal, Neurological, Oncology, Dermatology, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

  • Published In : May 2024
  • Code : CMI1728
  • Pages :205
  • Formats :
      Excel and PDF
  • Industry : Biotechnology

Market Concentration and Competitive Landscape

Cell Therapy Manufacturing Market Concentration By Players

To learn more about this report, request sample copy

Key Players Insights
  • WuXi AppTec, Inc.
  • Lineage Cell Therapeutics, Inc.
  • Healios Ltd. 
  • Lonza  
  • Merck KGaA
  • Takara Bio Inc.
  • Sumitomo Dainippon Pharma Co., LTD. 
  • Fujifilm Holdings Corporation 
  • Thermo Fisher Scientific, Inc.
  • Astellas Pharma Inc.
  • OXGENE
  • Cytiva
  • Exothera
  • Charles River Laboratories
  • Cell Therapies Pty Ltd
  • Bio-Techne
  • Catalent, Inc

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now

Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

Request Discount
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.